1)PEG-IFNα2b聚乙二醇干扰素α2b
1.Pharmacokinetic Behavior of PEG-IFNα2b in SD Rats聚乙二醇干扰素α2b在SD大鼠体内的药代动力学特征
英文短句/例句
1.Pharmacokinetic Behavior of PEG-IFNα2b in SD Rats聚乙二醇干扰素α2b在SD大鼠体内的药代动力学特征
2.Treatment of Peginterferon alfa-2a on Patients with Chronic Hepatitis B聚乙二醇干扰素α-2a治疗HBeAg阳性慢性乙型肝炎
3.The Relationship between Efficacy of PEG-interferon and HLA-DRB1 Alleles in the Patients with Chronic Hepatitis B;慢性乙型肝炎聚乙二醇干扰素疗效与HLA-DRB1等位基因的相关性研究
4.Clinlical Effect and Safety of Pegylated Interferonɑ-2a in the Treatment of Chronic Hepatitis B;聚乙二醇化干扰素ɑ-2a治疗慢性乙型肝炎的疗效与安全性
5.Efficacy of Peginterferon α-2a in HBeAg Positive Chronic Hepatitis B:Meta-analysis Study聚乙二醇干扰素α-2a治疗HBeAg阳性慢性乙型肝炎的Meta分析
6.Studies on related molecules to virological response to polyethylene glycol-interferon-alpha-2a therapy in patients with chronic hepatitis B聚乙二醇干扰素α2a治疗慢性乙型肝炎病毒学应答的相关分子研究
7.Clinical study of peg-interferon-alpha 2a antiviral therapy in patients with chronic hepatitis B聚乙二醇干扰素α-2a治疗慢性乙型肝炎临床分析
8.Study on Characterization of Polyethylene Glycolylated Recombinant Human Interferon α_(2b) and Preparation of Protective Additive in Freeze-drying Formulation;聚乙二醇化重组人干扰素α_（2b）性质及冻干保护剂的研究
9.Study on the Anti-hepatitis B Virus with Peg-IFNα-2a and IFNα-2a in Vitro and in Vivo;聚乙二醇化干扰素α-2a与干扰素α-2a在体内和体外的抗乙型肝炎病毒活性研究
10.Study on Pharmacokinetics of Recombinant Human IFN-ω Modified with PEG;聚乙二醇修饰重组人干扰素ω的药代动力学研究
11.Clinical Studies on the Combination of PEG-IFN α-2a with RBV to Treat Chronic Hepatitis C;聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎的临床研究
12.Different Methods to Determine the Purity of PEGylated Recombinant Human Interferon α-2b Injection不同方法测定聚乙二醇化重组人干扰素α-2b注射液的纯度
13.Treatment on Patients with Chronic Hepatitis C by Peginterferon with Ribavirin聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎临床观察
14.Study on Characterization of PEGylated and Native Consensus Interferon α重组复合α干扰素及其聚乙二醇化修饰产物理化性质研究
15.Case analysis of antigenic diversion of HBsAg in the patients treated with pegylated interferon α-2a聚乙二醇干扰素α-2a治疗慢性乙型病毒性肝炎HBsAg转阴影响因素分析
16.Factors that predict response of pegylated interferon α-2a on antigenic deversion of HBsAg among chronic hepatitis B patients聚乙二醇化干扰素α-2a治疗慢性乙型肝炎发生HBsAg转阴的相关因素探讨
17.The Analysis of Early Virological Response and Sustained Virological Response on Chronic Hepatitis B Patients with PEG Interferon α-2a Treatment;聚乙二醇干扰素α-2a治疗慢性乙肝患者的早期应答与持久应答关系分析
18.A Cost-effectiveness Analysis of Peginterferon and Nucleoside Analogues for HBeAg-Positive Chronic Hepatits B聚乙二醇干扰素和核苷类似物治疗e抗原阳性慢性乙型肝炎成本效果分析
相关短句/例句
Polyethylene glycol IFN α 2b conjugates聚乙二醇修饰干扰素α2b
3)Peg-interferon聚乙二醇干扰素
1.Conclusion:The effect of PEG-interferon combined with ribavirin treating chronic hepatitis C was better than common interferon.目的:观察聚乙二醇干扰素(PEG-INFa)联合利巴韦林治疗慢性丙型肝炎临床疗效。
4)interferon α2b干扰素α2b
1.The interferon α2b-loaded powder inhalant was surface-modifi ed with phospholipid by suspension- rotation evaporation coating method.采用混悬-旋转蒸发包衣法对供吸入干扰素α2b粉末进行表面修饰,并用扫描电镜和化学分析电子能谱分析颗粒表面,考察了修饰前后粉末的引湿性及溶解性,测试了不同湿度条件对粉雾剂有效药物体外沉积的影响。
5)IFN-α2b干扰素-α2b
1.Objective To observe the effect on chronic hepatitis B treated by IFN-α2b combination with oxymatrine due to failed treadment with lamivudine.目的观察苦参素与干扰素-α2b用于拉米夫定治疗慢性乙型肝炎失败后再治疗的疗效。
2.METHODS: Different doses of IFN-α2b were added to the HepG2.目的:体外研究干扰素-α2b(IFN-α2b)作用下乙肝病毒(HBV)突变机制。
6)IFNα2bα2b干扰素
1.Fusion Expression of Genes IFNα2b and Ag85B in Pichia pastoris;α2b干扰素基因与Ag85B基因在毕赤氏酵母中的融合表达
延伸阅读
聚乙二醇 聚乙二醇又称聚乙二醇醚，简称PEG，结构式为HO(CH2CH2O)nH，根据分子量大小不同，可从无色透明粘稠液体(分子量200～700)到白色脂状半固体(分子量1000～2000)直至坚硬的蜡状固体(分子量3000～20000)，相对密度(20℃／20 ℃)1．12～1.15。作为增韧利用的聚乙二醇主要是分子量200～600的室温下为无色透明的粘性液体，无味。易溶于水，溶于甲醇、乙醇、丙酮、醋酸乙酯、苯、甲苯、二氯乙烷、三氯乙烯等．不溶于脂肪烃。对酚类溶解能力强，当皮肤上附有苯酚、甲酚时，可用分子量约400的聚乙二醇除去。与硝酸纤维素、松香、酪阮可以混合．但对一般的合成树脂不溶解，对橡胶也不溶胀。吸湿性大。聚乙二醇在正常条件下是很稳定的，但在120 ℃或更高温度下能与空气中的氧发生氧化作用。加热至300 C产生断裂或热裂解。聚乙二醇不挥发．闪点高，对金屑无腐蚀性。无毒，对眼睛和皮肤无明显刺激，LD5033000～43000mg/kg。 用作环氧树脂和聚乙烯醇的增韧剂。 贮存于干燥的库房内，远离火源。
